Sampson JR - Search Results

1

Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.

Yang J, Kalogerou M, Gallacher J, Sampson JR, Shen MH. Yang J, et al. Among authors: sampson jr. Eur J Cancer. 2013 Apr;49(6):1479-90. doi: 10.1016/j.ejca.2012.10.027. Epub 2012 Dec 7. Eur J Cancer. 2013. PMID: 23228442

2

Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.

Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, Sampson JR, Cheadle JP. Jones AC, et al. Among authors: sampson jr. Hum Mol Genet. 1997 Nov;6(12):2155-61. doi: 10.1093/hmg/6.12.2155. Hum Mol Genet. 1997. PMID: 9328481

3

Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.

Parry L, Maynard JH, Patel A, Clifford SC, Morrissey C, Maher ER, Cheadle JP, Sampson JR. Parry L, et al. Among authors: sampson jr. Br J Cancer. 2001 Oct 19;85(8):1226-30. doi: 10.1054/bjoc.2001.2072. Br J Cancer. 2001. PMID: 11710839 Free PMC article.

4

TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.

Sampson JR. Sampson JR. Biochem Soc Trans. 2003 Jun;31(Pt 3):592-6. doi: 10.1042/bst0310592. Biochem Soc Trans. 2003. PMID: 12773162

5

A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.

Wilson C, Idziaszczyk S, Parry L, Guy C, Griffiths DF, Lazda E, Bayne RA, Smith AJ, Sampson JR, Cheadle JP. Wilson C, et al. Among authors: sampson jr. Hum Mol Genet. 2005 Jul 1;14(13):1839-50. doi: 10.1093/hmg/ddi190. Epub 2005 May 11. Hum Mol Genet. 2005. PMID: 15888477

6

Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.

Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE. Jiang WG, et al. Eur J Cancer. 2005 Jul;41(11):1628-36. doi: 10.1016/j.ejca.2005.03.023. Eur J Cancer. 2005. PMID: 15951164

7

Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.

Wilson C, Idziaszczyk S, Colley J, Humphreys V, Guy C, Maynard J, Sampson JR, Cheadle JP. Wilson C, et al. Among authors: sampson jr. Cancer Res. 2005 Nov 15;65(22):10179-82. doi: 10.1158/0008-5472.CAN-05-2688. Cancer Res. 2005. PMID: 16288003

8

Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice.

Wilson C, Bonnet C, Guy C, Idziaszczyk S, Colley J, Humphreys V, Maynard J, Sampson JR, Cheadle JP. Wilson C, et al. Among authors: sampson jr. Cancer Res. 2006 Aug 15;66(16):7934-8. doi: 10.1158/0008-5472.CAN-06-1740. Cancer Res. 2006. PMID: 16912167

9

Therapeutic targeting of mTOR in tuberous sclerosis.

Sampson JR. Sampson JR. Biochem Soc Trans. 2009 Feb;37(Pt 1):259-64. doi: 10.1042/BST0370259. Biochem Soc Trans. 2009. PMID: 19143643 Review.

10

Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence.

Dunlop EA, Dodd KM, Land SC, Davies PA, Martins N, Stuart H, McKee S, Kingswood C, Saggar A, Corderio I, Medeira AM, Kingston H, Sampson JR, Davies DM, Tee AR. Dunlop EA, et al. Among authors: sampson jr. Eur J Hum Genet. 2011 Jul;19(7):789-95. doi: 10.1038/ejhg.2011.38. Epub 2011 Mar 16. Eur J Hum Genet. 2011. PMID: 21407264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters